Apollomics, Inc. (NASDAQ:APLMW – Get Free Report) saw a significant increase in short interest in the month of May. As of May 29th, there was short interest totaling 24,869 shares, an increase of 60.2% from the May 14th total of 15,523 shares. Based on an average daily trading volume, of 73,878 shares, the days-to-cover ratio is presently 0.3 days.
Apollomics Stock Down 10.3%
Shares of APLMW stock opened at $0.01 on Wednesday. The company has a 50-day moving average of $0.01 and a two-hundred day moving average of $0.01. Apollomics has a 1-year low of $0.00 and a 1-year high of $0.05.
About Apollomics
Apollomics, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and potential commercialization of novel oncology therapies. Since its founding, the company has concentrated on creating targeted and immuno-oncology candidates designed to address unmet needs in solid tumors. Apollomics maintains headquarters in the United States with key research operations in China, leveraging a dual-site strategy to accelerate global development timelines.
The company’s pipeline encompasses a range of therapeutic modalities, including monoclonal antibodies, antibody-drug conjugates and bispecific constructs.
Further Reading
- Five stocks we like better than Apollomics
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for Apollomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollomics and related companies with MarketBeat.com's FREE daily email newsletter.
